Authors:
GUREVITCH J
FROLKIS I
YUHAS Y
PAZ Y
MATSA M
MOHR R
YAKIREVICH V
Citation: J. Gurevitch et al., TUMOR-NECROSIS-FACTOR-ALPHA IS RELEASED FROM THE ISOLATED HEART UNDERGOING ISCHEMIA AND REPERFUSION, Journal of the American College of Cardiology, 28(1), 1996, pp. 247-252
Authors:
OBERHOFF M
DUDA L
KARL J
MOHR R
ERKER G
FROHLICH R
GREHL M
Citation: M. Oberhoff et al., THE ISOCYANATE ROUTE TO CYCLOPENTADIENYL-CARBOXAMIDE-SUBSTITUTED AND CYCLOPENTADIENYL-AMINO ESTER-SUBSTITUTED METALLOCENE COMPLEXES, Organometallics, 15(19), 1996, pp. 4005-4011
Authors:
GUREVITCH J
MILLER HI
KREMER A
PAZ Y
MOHR R
YAKIREVITCH V
Citation: J. Gurevitch et al., HIGH-DOSE NITRATES FOR MYOCARDIAL REVASCULARIZATION WITH COMPOSITE ARTERIAL GRAFTS, Circulation, 94(8), 1996, pp. 1362-1362
Authors:
LIMA L
SUBRAMANIAN VA
BURDON TA
AKINS CW
BENETTI FJ
MOHR R
Citation: L. Lima et al., PORT-ACCESS CORONARY-ARTERY BYPASS WITH CARDIOPLEGIC ARREST - ACUTE AND CHRONIC CANINE STUDIES - DISCUSSION, The Annals of thoracic surgery, 62(2), 1996, pp. 441-441
Authors:
DORIN D
COHEN L
DELVILLAR K
POULLET P
MOHR R
WHITEWAY M
WITTE O
TAMANOI F
Citation: D. Dorin et al., KIR, A NOVEL RAS-FAMILY G-PROTEIN, INDUCES INVASIVE PSEUDOHYPHAL GROWTH IN SACCHAROMYCES-CEREVISIAE, Oncogene, 11(11), 1995, pp. 2267-2271
Citation: A. Buschauer et al., SYNTHESIS AND HISTAMINE H-2-RECEPTOR ANTAGONIST ACTIVITY OF 4-(1-PYRAZOLYL)BUTANAMIDES, GUANIDINOPYRAZOLES, AND RELATED-COMPOUNDS, Archiv der pharmazie, 328(4), 1995, pp. 349-358
Citation: R. Mohr et al., RELATIVE 3D RECONSTRUCTION USING MULTIPLE UNCALIBRATED IMAGES, The International journal of robotics research, 14(6), 1995, pp. 619-632
Citation: H. Drost et al., HIGH DEPOSITION RATE COATING WITH NANODISPERSE SIC POWDER BY PLASMA-ASSISTED PULSE PYROLYSIS, Surface & coatings technology, 74-5(1-3), 1995, pp. 508-511
Authors:
LAVEE J
SHINFELD A
SAVION N
THALER M
MOHR R
GOOR DA
Citation: J. Lavee et al., IRRADIATION OF FRESH WHOLE-BLOOD FOR PREVENTION OF TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE DOES NOT IMPAIR PLATELET-FUNCTION AND CLINICAL HEMOSTASIS AFTER OPEN-HEART-SURGERY, Vox sanguinis, 69(2), 1995, pp. 104-109
Citation: Y. Moshkovitz et al., CORONARY-ARTERY BYPASS WITHOUT CARDIOPULMONARY BYPASS - ANALYSIS OF SHORT-TERM AND MIDTERM OUTCOME IN 220 PATIENTS, Journal of thoracic and cardiovascular surgery, 110(4), 1995, pp. 979-987
Authors:
SHINFELD A
ZIPPEL D
LAVEE J
LUSKY A
SHINAR E
SAVION N
MOHR R
Citation: A. Shinfeld et al., APROTININ IMPROVES HEMOSTASIS AFTER CARDIOPULMONARY BYPASS BETTER THAN SINGLE-DONOR PLATELET CONCENTRATE, The Annals of thoracic surgery, 59(4), 1995, pp. 872-876
Authors:
RIE KT
GEBAUER A
WOHLE J
ERKER G
MOHR R
SARTER C
Citation: Kt. Rie et al., DEPOSITION OF HARD COATINGS TYPE (B,C,N) AT LOW COATING TEMPERATURES BY PACVD, Materialwissenschaft und Werkstofftechnik, 25(11), 1994, pp. 431-434
Citation: R. Mohr et al., LOWEST EMISSIONS FROM TCF PULP PRODUCTION WITH SUPER-BATCH KRAFT PULPPROCESS, Das Papier, 48(10A), 1994, pp. 220000001-220000006
Authors:
COHEN L
MOHR R
CHEN YY
HUANG M
KATO R
DORIN D
TAMANOI F
GOGA A
AFAR D
ROSENBERG N
WITTE O
Citation: L. Cohen et al., TRANSCRIPTIONAL ACTIVATION OF A RAS-LIKE GENE (KIR) BY ONCOGENIC TYROSINE KINASES, Proceedings of the National Academy of Sciences of the United Statesof America, 91(26), 1994, pp. 12448-12452
Citation: A. Yellin et al., CORONARY REVASCULARIZATION AND PULMONARY LOBECTOMY WITHOUT CARDIOPULMONARY BYPASS, Journal of thoracic and cardiovascular surgery, 108(4), 1994, pp. 797-799
Citation: Y. Moshkovitz et al., CORONARY-BYPASS REOPERATIONS WITHOUT CARDIOPULMONARY BYPASS - THE ISRAELI EXPERIENCE, Journal of Cardiovascular Surgery, 35(6), 1994, pp. 59-62
Citation: Y. Moshkovitz et al., CORONARY-ARTERY BYPASS WITHOUT CARDIOPULMONARY BYPASS FOR PATIENTS WITH SEVERE LEFT-VENTRICULAR DYSFUNCTION, Journal of Cardiovascular Surgery, 35(6), 1994, pp. 227-231
Citation: R. Schellin et R. Mohr, A MONOLITHICALLY-INTEGRATED TRANSISTOR MICROPHONE - MODELING AND THEORETICAL BEHAVIOR, Sensors and actuators. A, Physical, 37-8, 1993, pp. 666-673